相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index
Shin-ya Kawashiri et al.
Modern Rheumatology (2014)
AT-Rich-Interactive Domain-Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt-Induced Th17 Cell Differentiation
Yukari Saito et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Autoimmune Rheumatic Diseases 3 Immunopathogenic mechanisms of systemic autoimmune disease
Marie Wahren-Herlenius et al.
LANCET (2013)
Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Pretreatment synovial transcriptional pro le is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab
Vanessa E. Hogan et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Janus-like effects of type I interferon in autoimmune diseases
Robert C. Axtell et al.
IMMUNOLOGICAL REVIEWS (2012)
Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
Erik J. M. Toonen et al.
PLOS ONE (2012)
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
Hennie G. Raterman et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis
Saskia Vosslamber et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases
Terrance P. O'Hanlon et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Tumour necrosis factor α-308G→A polymorphism is not associated with response to TNFα blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis
Stephan Pavy et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Relationship Between the Type I Interferon Signature and the Response to Rituximab in Rheumatoid Arthritis Patients
Rogier M. Thurlings et al.
ARTHRITIS AND RHEUMATISM (2010)
Association of the Response to Tumor Necrosis Factor Antagonists With Plasma Type I Interferon Activity and Interferon-β/α Ratios in Rheumatoid Arthritis Patients
Clio P. Mavragani et al.
ARTHRITIS AND RHEUMATISM (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Psoriasis during interferon beta treatment for multiple sclerosis
Loredana La Mantia et al.
NEUROLOGICAL SCIENCES (2010)
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
Johan Lindberg et al.
PLOS ONE (2010)
Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment
Lisa G. M. van Baarsen et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
C. Potter et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells
Motohiko Tanino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-α monoclonal antibody, infliximab
N. Sekiguchi et al.
RHEUMATOLOGY (2008)
Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
Dirk Koczan et al.
ARTHRITIS RESEARCH & THERAPY (2008)
New therapies for treatment of rheumatoid arthritis
Josef S. Smolen et al.
LANCET (2007)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
T. C. T. M. van der Pouw Kraan et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Nutrient-gene interaction in ageing and successful ageing - A single nutrient (zinc) and some target genes related to inflammatory/immune response
Eugenio Mocchegiani et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
Thierry Lequerre et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Autoimmune disease complicating antiviral therapy for hepatitis C virus infection
LE Wilson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Metallothionein: The multipurpose protein
P Coyle et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Cross talk of the interferon-α/β signalling complex with gp130 for effective interleukin-6 signalling
Y Mitani et al.
GENES TO CELLS (2001)
分享论文
